Corcept Therapeutics
CORT
$25.06
Share price
4.94%
Change (1 day)
11.92%
Change (1 year)
Categories
Operating Margin for Corcept Therapeutics (CORT)
Operating Margin as of May 2024 (TTM): 28.91%
According to Corcept Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 28.91%. At the end of 2022 the company had an Operating Margin of 28.91%.
Operating Margin history for Corcept Therapeutics from 2006 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 28.91% | -15.35% |
| 2021 | 34.16% | -8.15% |
| 2020 | 37.19% | -2.31% |
| 2019 | 38.07% | 3.79% |
| 2018 | 36.68% | 10.58% |
| 2017 | 33.17% | 231.37% |
| 2016 | 10.01% | -178.55% |
| 2015 | -12.74% | -89.22% |
| 2014 | -118.20% | -73.39% |
| 2013 | -444.25% | -61.39% |
| 2012 | -1,150.53% | |
| 2009 | -69,827.59% | 641.22% |
| 2008 | -9,420.57% | 270.82% |
| 2007 | -2,540.46% | -70.8% |
| 2006 | -8,701.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -20.86% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -40.26% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 19.72% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -14.70% | 🇺🇸 USA |
 Merck MRK | 27.73% | -4.08% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -33.45% | 🇺🇸 USA |
 MannKind Corp MNKD | -87.60% | -403.01% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -343.04% | -1,286.58% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -83.29% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.